Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-05 Sale | 2024-02-06 6:29 pm | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer | 6,212 | $4.86 | $30,190 | 380,356 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:03 pm | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer | 6,433 | $4.95 | $31,843 | 139,932 (Direct) | View |
| 2023-02-06 Sale | 2023-02-08 7:32 pm | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer | 6,476 | $4.24 | $27,458 | 139,387 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-29 Option Award | 2024-09-03 4:08 pm | N/A 2034-08-28 | OCULAR THERAPEUTIX INC | OCUL | Notman Donald See Remarks | 44,636 | $0 | 242,590 (Direct) | View |
| 2024-02-03 Option Award | 2024-02-06 6:29 pm | N/A 2034-02-02 | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer | 246,636 | $0 | 380,356 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 7:33 pm | N/A 2033-01-29 | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer | 222,223 | $0 | 312,530 (Direct) | View |
| 2022-02-03 Option Award | 2022-02-07 7:34 pm | N/A 2032-02-02 | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer | 222,223 | $0 | 248,299 (Direct) | View |
| 2021-02-17 Option Award | 2021-02-19 4:30 pm | N/A 2031-02-16 | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer | 190,000 | $0 | 190,000 (Direct) | View |
| 2020-01-30 Option Award | 2020-02-03 6:27 pm | N/A 2030-01-29 | OCULAR THERAPEUTIX INC | OCUL | Notman Donald Chief Financial Officer | 215,000 | $0 | 215,000 (Direct) | View |